Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT01977274

Predictive Clinical and Biological Parameters in Gynecological Cancer

Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • gynecological cancer suspicion
  • age > 18
  • signed informed consent

Exclusion criteria

  • emergency

Exclusion criteria

after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).

Treatment and study plan

gynecological cancer

Other

blood and tumor samples

Primary outcomes

  1. molecular alteration in gynecological cancer

    Time frame: average of 4 weeks after diagnosis

    gene expression level

Secondary outcomes

  1. relation between molecular alteration and clinical and histological characteristics

    Time frame: up to 10 years

    hazard ratio between molecular alteration and clinico-histological characteristics

Sponsors and collaborators

Lead sponsor

Institut Paoli-Calmettes

Other

Registry information

Official study title

Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010

Acronym: GC-BIO

Important dates

Study start
2013
Primary completion
2033
Study completion
2035
First posted
Nov 6, 2013
Registry last updated
Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.